Publications in collaboration with researchers from Hospital do Meixoeiro (11)

2015

  1. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors

    Annals of General Psychiatry, Vol. 14, Núm. 1

  2. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

    Drug Design, Development and Therapy, Vol. 9, pp. 4329-4340

2014

  1. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy

    Journal of Affective Disorders, Vol. 163, pp. 47-55

2013

  1. A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

    Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 164-174

  2. Improving treatment adherence in your patients with schizophrenia: The STAY initiative

    Clinical Drug Investigation, Vol. 33, Núm. 2, pp. 97-107

  3. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

    Social Psychiatry and Psychiatric Epidemiology, Vol. 48, Núm. 6, pp. 985-996

2012

  1. Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

    Clinical Practice and Epidemiology in Mental Health, Vol. 8, pp. 158-168

  2. Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain

    ClinicoEconomics and Outcomes Research, Vol. 4, Núm. 1, pp. 157-168

2006

  1. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia

    Journal of Clinical Psychopharmacology, Vol. 26, Núm. 3, pp. 238-249

  2. Análisis de los patrones de prescripción de antipsicóticos en psiquiatría

    Actas Espanolas de Psiquiatria, Vol. 34, Núm. 5, pp. 323-329

  3. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 30, Núm. 8, pp. 1515-1522